MNOV – Medicinova Inc
MediciNova, Inc.MNOV
$1.41Name : MediciNova, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $69,155,208.00
EPSttm : -0.25
MediciNova, Inc.
$1.41
9.03%$0.14Float Short %
1.63
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
EPS Last/This Y
-0.27
EPS This/Next Y
0.12
Price
1.41
Target Price
9
Analyst Recom
1
Performance Q
8.46
Relative Volume
0.16
Beta
0.48
Ticker: MNOV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | MNOV | 1.21 | 0.00 | 0.00 | 264 |
| 2025-10-21 | MNOV | 1.22 | 0.00 | 999.99 | 360 |
| 2025-10-22 | MNOV | 1.225 | 0.01 | 999.99 | 362 |
| 2025-10-23 | MNOV | 1.215 | 0.01 | 999.99 | 363 |
| 2025-10-24 | MNOV | 1.23 | 0.01 | 999.99 | 364 |
| 2025-10-27 | MNOV | 1.21 | 0.01 | 999.99 | 364 |
| 2025-10-28 | MNOV | 1.21 | 0.01 | 999.99 | 364 |
| 2025-10-29 | MNOV | 1.19 | 0.02 | 0.00 | 365 |
| 2025-10-30 | MNOV | 1.19 | 0.02 | 0.00 | 366 |
| 2025-10-31 | MNOV | 1.63 | 0.02 | 0.04 | 368 |
| 2025-11-03 | MNOV | 1.49 | 0.02 | 0.01 | 1291 |
| 2025-11-04 | MNOV | 1.44 | 0.02 | 0.00 | 1301 |
| 2025-11-05 | MNOV | 1.5 | 0.02 | 0.00 | 1289 |
| 2025-11-06 | MNOV | 1.405 | 0.02 | 0.00 | 1289 |
| 2025-11-07 | MNOV | 1.435 | 0.02 | 0.00 | 1289 |
| 2025-11-10 | MNOV | 1.42 | 0.02 | 999.99 | 1276 |
| 2025-11-11 | MNOV | 1.6 | 0.02 | 0.00 | 1274 |
| 2025-11-12 | MNOV | 1.595 | 0.02 | 0.00 | 1274 |
| 2025-11-13 | MNOV | 1.53 | 0.02 | 0.00 | 1273 |
| 2025-11-14 | MNOV | 1.56 | 0.02 | 0.00 | 1272 |
| 2025-11-17 | MNOV | 1.42 | 0.02 | 0.00 | 1272 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | MNOV | 1.21 | - | - | -0.50 |
| 2025-10-21 | MNOV | 1.22 | - | - | -0.50 |
| 2025-10-22 | MNOV | 1.22 | - | - | -0.50 |
| 2025-10-23 | MNOV | 1.22 | - | - | -0.50 |
| 2025-10-24 | MNOV | 1.23 | - | - | -0.50 |
| 2025-10-27 | MNOV | 1.21 | - | - | -0.50 |
| 2025-10-28 | MNOV | 1.21 | - | - | -0.50 |
| 2025-10-29 | MNOV | 1.20 | - | - | -0.50 |
| 2025-10-30 | MNOV | 1.19 | - | - | -0.50 |
| 2025-10-31 | MNOV | 1.66 | - | - | -0.50 |
| 2025-11-03 | MNOV | 1.50 | - | - | -0.50 |
| 2025-11-04 | MNOV | 1.45 | - | - | -0.50 |
| 2025-11-05 | MNOV | 1.50 | - | - | -0.50 |
| 2025-11-06 | MNOV | 1.34 | - | - | -0.50 |
| 2025-11-07 | MNOV | 1.42 | - | - | -0.50 |
| 2025-11-10 | MNOV | 1.41 | - | - | -0.50 |
| 2025-11-11 | MNOV | 1.61 | - | - | -0.50 |
| 2025-11-12 | MNOV | 1.58 | - | - | -0.50 |
| 2025-11-13 | MNOV | 1.53 | - | - | -0.50 |
| 2025-11-14 | MNOV | 1.55 | - | - | -0.50 |
| 2025-11-17 | MNOV | 1.41 | -100.0 | - | -0.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | MNOV | 0.00 | -0.08 | 0.28 |
| 2025-10-21 | MNOV | 0.00 | -0.08 | 0.28 |
| 2025-10-22 | MNOV | 0.00 | -0.08 | 0.28 |
| 2025-10-23 | MNOV | 0.00 | -0.08 | 0.28 |
| 2025-10-24 | MNOV | 0.00 | -0.08 | 0.28 |
| 2025-10-27 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-10-28 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-10-29 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-10-30 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-10-31 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-03 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-04 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-05 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-06 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-07 | MNOV | 0.00 | -0.08 | 0.26 |
| 2025-11-10 | MNOV | 0.00 | -0.04 | 0.26 |
| 2025-11-11 | MNOV | 0.00 | -0.04 | 0.26 |
| 2025-11-12 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-13 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-14 | MNOV | 0.00 | -0.04 | 1.63 |
| 2025-11-17 | MNOV | 0.00 | -0.15 | 1.63 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-0.15
Beta
0.48
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
21
Growth Score
19
Sentiment Score
68
Actual DrawDown %
86.9
Max Drawdown 5-Year %
-87.1
Target Price
9
P/E
Forward P/E
PEG
P/S
265.98
P/B
1.57
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.5
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-4656.65
Relative Volume
0.16
Return on Equity vs Sector %
-52.2
Return on Equity vs Industry %
-37.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MediciNova, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading